Erin Wallace | Authors


Immunotherapy and Chemotherapy Trial Arm for Sarcoma Commences

September 24, 2015

A sarcoma study arm of the phase II portion of the multiarm PembroPlus clinical trial that combines immunotherapy with chemotherapy has commenced at Cancer Treatment Centers of America (CTCA), Western Regional Medical Center, Goodyear, Arizona

Significant OS Benefit Seen With Docetaxel and ADT in Hormone-Sensitive Prostate Cancer

September 09, 2015

Administering 6 cycles of docetaxel at the beginning of androgen-deprivation therapy (ADT) to patients with metastatic, hormone-sensitive prostate cancer (mHSPC) resulted in a significantly longer overall survival (OS) than ADT alone.